Evaluation of the Efficacy and Neurological Effects of Dry Needling in the Treatment of Myofascial Pain Syndrome
1 other identifier
interventional
40
1 country
1
Brief Summary
AIM OF INVESTIGATION: To evaluate in a prospective, randomized, sham-controlled study the pattern of analgesic efficacy of trigger point dry needling in Myofascial Pain Syndrome (MPS) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 27, 2014
CompletedFirst Posted
Study publicly available on registry
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedMay 3, 2018
April 1, 2015
1 year
June 27, 2014
May 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analgesic effects of dry needling
Maximum, average and lowest pain will be evaluated daily 7 days before the treatment, on the day of the treatment, and also 7 days after the treatment is done.
Within the first 7 days after treatment
Secondary Outcomes (1)
Neurologic effects of dry needling
Within the first 7 days after treatment
Study Arms (2)
Dry needling
ACTIVE COMPARATORDry needling for myofascial pain syndrome, in the trapezius muscle.
Sham needling
SHAM COMPARATORSuperficial dry needling in the trapezius muscle
Interventions
Dry needling of the painful muscles, with an acupuncture needle 0,25 x 40mm
Eligibility Criteria
You may qualify if:
- Assymetric shoulder pain (VAS on painful side : VAS on non painful side \> 2:1)
- Pain due to unilateral Myofascial Pain Syndrome of the trapezius muscle.
- Chronic pain, with duration of at least 3 months and VAS \> 40/100
- Patients with pain at least 4 days in a week
- Patients without neurological pain, as in DN4 score less than 4
- Age over 18 years
- Patients with stable drug treatment over at least 15 days, without any acute pharmacological changes during the study
- Patients who read, understood and signed the Free and Clarified Consent Term
You may not qualify if:
- Patients with major depression, according to DSM-IV criteria
- History of bipolar mood disorder, panic syndrome or psychosis
- Intermittent pain history
- Refusal to sing the Consent Term
- Patients not able to attend all the follow-ups
- Patients with another pain syndrome in shoulders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
São Paulo, São Paulo, 05403-010, Brazil
Related Publications (14)
Yap EC. Myofascial pain--an overview. Ann Acad Med Singap. 2007 Jan;36(1):43-8.
PMID: 17285185BACKGROUNDGerwin RD. Classification, epidemiology, and natural history of myofascial pain syndrome. Curr Pain Headache Rep. 2001 Oct;5(5):412-20. doi: 10.1007/s11916-001-0052-8.
PMID: 11560806BACKGROUNDGa H, Choi JH, Park CH, Yoon HJ. Dry needling of trigger points with and without paraspinal needling in myofascial pain syndromes in elderly patients. J Altern Complement Med. 2007 Jul-Aug;13(6):617-24. doi: 10.1089/acm.2006.6371.
PMID: 17718644BACKGROUNDCummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil. 2001 Jul;82(7):986-92. doi: 10.1053/apmr.2001.24023.
PMID: 11441390BACKGROUNDMcCain GA, Bell DA, Mai FM, Halliday PD. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum. 1988 Sep;31(9):1135-41. doi: 10.1002/art.1780310908.
PMID: 3048273BACKGROUNDGiamberardino MA. Referred muscle pain/hyperalgesia and central sensitisation. J Rehabil Med. 2003 May;(41 Suppl):85-8. doi: 10.1080/16501960310010205.
PMID: 12817663BACKGROUNDGe HY, Fernandez-de-las-Penas C, Arendt-Nielsen L. Sympathetic facilitation of hyperalgesia evoked from myofascial tender and trigger points in patients with unilateral shoulder pain. Clin Neurophysiol. 2006 Jul;117(7):1545-50. doi: 10.1016/j.clinph.2006.03.026. Epub 2006 Jun 5.
PMID: 16737848BACKGROUNDHong CZ, Simons DG. Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points. Arch Phys Med Rehabil. 1998 Jul;79(7):863-72. doi: 10.1016/s0003-9993(98)90371-9.
PMID: 9685106BACKGROUNDHong CZ. Treatment of myofascial pain syndrome. Curr Pain Headache Rep. 2006 Oct;10(5):345-9. doi: 10.1007/s11916-006-0058-3.
PMID: 16945250BACKGROUNDGiamberardino MA, Affaitati G, Fabrizio A, Costantini R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol. 2011 Apr;25(2):185-98. doi: 10.1016/j.berh.2011.01.002.
PMID: 22094195BACKGROUNDSkootsky SA, Jaeger B, Oye RK. Prevalence of myofascial pain in general internal medicine practice. West J Med. 1989 Aug;151(2):157-60.
PMID: 2788962BACKGROUNDSOLA AE, RODENBERGER ML, GETTYS BB. Incidence of hypersensitive areas in posterior shoulder muscles; a survey of two hundred young adults. Am J Phys Med. 1955 Dec;34(6):585-90. No abstract available.
PMID: 13268620BACKGROUNDHong CZ. Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med Rehabil. 1994 Jul-Aug;73(4):256-63. doi: 10.1097/00002060-199407000-00006.
PMID: 8043247BACKGROUNDGe HY, Fernandez-de-Las-Penas C, Madeleine P, Arendt-Nielsen L. Topographical mapping and mechanical pain sensitivity of myofascial trigger points in the infraspinatus muscle. Eur J Pain. 2008 Oct;12(7):859-65. doi: 10.1016/j.ejpain.2007.12.005. Epub 2008 Jan 18.
PMID: 18203637BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Daniel C Andrade, M.D., P.h.D.
University of Sao Paulo
- PRINCIPAL INVESTIGATOR
Juliana T Toma, M.D.
University of Sao Paulo
- PRINCIPAL INVESTIGATOR
Irina Raicher, M.D.
University of Sao Paulo
- STUDY DIRECTOR
Manoel J Teixeira, M.D., P.h.D.
University of Sao Paulo
- PRINCIPAL INVESTIGATOR
Helena H Kaziyama, M.D.
University of Sao Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2014
First Posted
July 1, 2014
Study Start
February 1, 2014
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
May 3, 2018
Record last verified: 2015-04